Guidance, NICE advice and quality standards in development | Guidance

Showing 361 to 370 of 405

Sort by

Guidance, NICE advice and quality standards in development
Title	Type	Expected publication date
Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy [ID4070]	Technology appraisal guidance	TBC
Tisotumab vedotin for treating recurrent or metastatic cervical cancer after systemic therapy [ID3753]	Technology appraisal guidance	TBC
Tobacco: preventing uptake, promoting quitting and treating dependence - Cytisine for smoking cessation	NICE guideline	4 February 2025
Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]	Technology appraisal guidance	TBC
Topical Antimicrobial dressings for wound care: Late stage assessment	Health technology evaluation	22 May 2025
Topical rapamycin for treating facial angiofibromas associated with tuberous sclerosis complex in people 6 years and over [ID6391]	Technology appraisal guidance	TBC
Total hip arthroplasty using the superpath approach for osteoarthritis	Interventional procedures guidance	TBC
Tralokinumab for treating moderate to severe atopic dermatitis [ID3734]	Technology appraisal guidance	TBC
Transcatheter aortic valve implantation for native aortic valve regurgitation	Interventional procedures guidance	11 June 2025
Transcatheter heart valves for transcatheter aortic valve implantation to treat aortic stenosis: Late stage assessment	Health technology evaluation	8 January 2025